Advert: GoIndustry032010Leader
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: UMAFeb2010_HouseMPU
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home
Hline
LATEST WORLD NEWS
Abbott Labs to buy Facet Biotech in $722 million deal
Having rejected much lower hostile bids from partner Biogen Idec last year, Facet Biotech Corp has agreed to be acquired by Abbott Laboratories for $27 per share

FDA panel backs InterMune's Esbriet for IPF
 Shares in InterMune will soar today after advisors to the US Food and Drug Administration voted in favour of recommending Esbriet for approval as a treatment for lung scarring

Arrow More World News articles
Ark/Oxford BioMedica merger touted as Cerepro file is pulled
Ark Therapeutics is in talks about a possible sale after European regulators informed the UK firm that an expensive additional clinical trial is needed before its brain cancer drug Cerepro could be given the green light

FDA rejects Actelion's Zavesca for rare NP-C disease
Actelion’s bid to get a new use approved for Gaucher disease drug Zavesca has suffered a setback after regulators in the USA asked more information on the drug as a treatment for a rarer condition
LATEST JOBS
Arrow   Clinical Nurse Advisor - Surgical & Critical Care
Arrow   BUSINESS DEVELOPMENT MANAGER - HOMECARE
Arrow   Secondary Care Representative
Arrow   Theatre Sales Representative- Theatre Consumables
Arrow   Marketing Manager
Arrow   Business Manager - Oncology
Arrow   PRODUCT MANAGER - HOMECARE
Arrow   Sales Specialist - Surgical
Arrow   Part-time Medical Representative
Arrow   Territory Manger- North-West
Advert: ABPIJan2010PT
LATEST CLINICAL NEWS
Arrow Quintiles expands Phase I capacity in London
Arrow WuXi delivers on profit but guidance disappoints
Arrow Kendle establishing operations centre in Indian economic zone
Arrow WuXi links with Janssen division on preclinical services
Arrow More Clinical News articles
LATEST UK NEWS
Arrow Government gets tough on parallel exports
Arrow Medco Health bursts onto UK pharmacy homecare market
Arrow Remicade and Humira clear another hurdle to NHS use
Arrow Roche’s MabThera on the brink of NICE green light for leukaemia
Arrow More UK News articles
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
PHARMATIMES MAGAZINE FEATURE PHARMATIMES MAGAZINE FEATURE
The information highway
Peter Mansell explores the sometimes contentious relationship between journalism and the PR sector 		Putting the patient at the centre
Relying on high-tech channels to achieve
success in patient programmes ignores one
fundamental point, says Adam Fleming
– the patient should be at the centre of your
planning
Arrow More articles
Arrow Subscribe
Arrow More articles
Arrow Subscribe
line
flickrtwitteryoutube